Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Price Target at $20.40
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have updated their coverage on the […]
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have updated their coverage on the […]
